P572-0613 Screening compound: N-(3-fluoro-4-methylphenyl)-2-[7-methyl-3-oxo-5-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide

P572-0613 Screening compound: N-(3-fluoro-4-methylphenyl)-2-[7-methyl-3-oxo-5-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide
P572-0613 Screening compound: N-(3-fluoro-4-methylphenyl)-2-[7-methyl-3-oxo-5-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P572-0613
N-(3-fluoro-4-methylphenyl)-2-[7-methyl-3-oxo-5-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P572-0613

Molecular Formula

C19H21FN6O2 (C19 H21 FN6 O2)

Compound Name

N-(3-fluoro-4-methylphenyl)-2-[7-methyl-3-oxo-5-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide

IUPAC name

N-(3-fluoro-4-methylphenyl)-2-[7-methyl-3-oxo-5-(pyrrolidin-1-yl)-2H3H-[124]triazolo[43-c]pyrimidin-2-yl]acetamide

SMILES

Cc(ccc(NC(CN(C1=O)N=C2N1C(N1CCCC1)=NC(C)=C2)=O)c1)c1F

InChI

InChI=1S/C19H21FN6O2/c1-12-5-6-14(10-15(12)20)22-17(27)11-25-19(28)26-16(23-25)9-13(2)21-18(26)24-7-3-4-8-24/h5-6,9-10H,3-4,7-8,11H2,1-2H3,(H,22,27)

InChI Key

FFPRLIDQIHUSII-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27604517

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

384.41

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.771

Distribution Coefficient, logD

2.771

Water Solubility, LogSw

-3.02

Polar Surface Area

68.712

Acid Dissociation Constant (pKa)

11.33

Base Dissociation Constant (pKb)

3.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.80

P572-0613 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with P572-0613 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P572-0613?
Check Price and Availability of P572-0613, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P572-0613 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P572-0613
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P572-0613
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P572-0613 available by request